Report overview
The global Pet Disease Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Parasiticides Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pet Disease Drugs include Merck & Co., Inc., Ceva, Vetoquinol S.A., Zoetis, Virbac, Bimeda, Calier, Boehringer Ingelheim and Elanco Animal Health, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
These drugs are used to quiet anxious pets or help in reducing anxiety associated with various behavioral issues in pets.
This report aims to provide a comprehensive presentation of the global market for Pet Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Disease Drugs. This report contains market size and forecasts of Pet Disease Drugs in global, including the following market information:
Global Pet Disease Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Pet Disease Drugs Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Pet Disease Drugs companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pet Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Disease Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pet Disease Drugs Market Segment Percentages, by Type, 2023 (%)
Parasiticides
Anti-infectives
Anti-inflammatory
Analgesics
Others
Global Pet Disease Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pet Disease Drugs Market Segment Percentages, by Application, 2023 (%)
Infectious Diseases
Dermatologic Diseases
Pain
Orthopedic Diseases
Behavioral Diseases
Other
Global Pet Disease Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pet Disease Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Disease Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Pet Disease Drugs revenues share in global market, 2023 (%)
Key companies Pet Disease Drugs sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Pet Disease Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc.
Ceva
Vetoquinol S.A.
Zoetis
Virbac
Bimeda
Calier
Boehringer Ingelheim
Elanco Animal Health
Dechra Pharmaceuticals
Norbrook Laboratories
Chanelle Pharma
K-Laser USA
Assisi Animal Health
Multi Radiance Medical
Avazzia
SOUND Technologies
IRM Enterprises
Ashish Life Science
Century Pharmaceuticals
VETINDIA Pharmaceuticals
Ourofino Animal Health
SeQuent Scientific
LABINDIA Healthcare
Morvel Laboratories
Richter Pharma
Zuche Pharmaceuticals
Fidelis Animal Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pet Disease Drugs, market overview.
Chapter 2: Global Pet Disease Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pet Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pet Disease Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
